N/A
N=24
Communication Strategy to PROMOTE HPV Vaccination in Pharmacies: PROMOTE Study
Human Papillomavirus Infection
Bottom Line
View on ClinicalTrials.gov: NCT04660331 ↗Enrolled (actual)
24
Serious AEs
—
Results posted
Oct 2024
Primary outcome: Primary: Acceptability of Providing HPV Vaccination to Children and of the Proposed Communication Strategy to Support HPV Vaccination — 4.1 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Communication Intervention (Other); Communication Skills Training (Other); Healthcare Activity (Behavioral); Survey Administration (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Fred Hutchinson Cancer Center
- Primary completion
- Jul 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Acceptability of Providing HPV Vaccination to Children and of the Proposed Communication Strategy to Support HPV Vaccination |
4.1 | — |
| PRIMARY Appropriateness of Providing HPV Vaccination to Children and of the Proposed Communication Strategy to Support HPV Vaccination |
4.0 | — |
| PRIMARY Feasibility of Providing HPV Vaccination to Children and of the Proposed Communication Strategy to Support HPV Vaccination |
4.1 | — |
| PRIMARY Self-efficacy of Providing HPV Vaccination |
4.2; 4.3; 2.8; 3.4; 2.7; 3.5 | — |
| PRIMARY Adoption of HPV Vaccination |
2; 20 | — |
| PRIMARY Adoption of Other Adolescent Vaccines |
75; 145 | — |
Summary
This trial investigates how a communication strategy works in increasing human papillomavirus (HPV) vaccines in community pharmacies among adolescents. Although pharmacies are vaccine providers, low vaccination rates are persistent as a result of low awareness of pharmacy services and poor engagement by pharmacy staff with adolescents about vaccines. The purpose of this study is to test a communication strategy that identifies vaccine-eligible children and teaches pharmacy staff how to effectively communicate with them about HPV vaccination in order to increase HPV vaccination rates.
Eligibility Criteria
Inclusion Criteria
- AIM 1 (PARENTS/GUARDIANS): Individuals with children between the ages of 9-17 in their care who are English speakers, live in Washington state, and have access to a telephone or computer with internet access (up to 12 parents)
- AIM 1 (PHARMACY STAFF): Employed at a Western Washington Bartell Drugs pharmacy sites and have access to a telephone or computer with internet access
- AIM 2: Pharmacy staff employed at up to four independent pharmacies in western Washington state who speak English and have access to a computer with internet access
Exclusion Criteria
- AIM 1 (PARENTS/GUARDIANS): Those who object to having their interview audio recorded
- AIM 1 and AIM 2 (PHARMACY STAFF): Floaters/per diem. Those who object to having their interview audio recorded
Data sourced from ClinicalTrials.gov (NCT04660331). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.